Table 1

Treatment**	Concentration (ppm)	Fungi tested
Treatment**	Concentration (ppm)	Fusarium oxysporum	Fusarium solani	Rhizoctonia solani	Sclerotium rolfesii
A	100	18.9 e	22.2 c	26.7 c	28.9 c
	200	25.6 c	29.9 c	41.1 d	43.3 d
	400	46.7 d	45.6 d	51.1 bc	52.2 bc
	600	61.1 b	63.3 b	66.7 b	68.9 b
	800	100 a	100 a	100 a	100 a
B	100	21.1 c	24.4 c	27.8 c	31.1 cd
	200	26.7 c	38.9 cd	35.6 cd	42.2 d
	400	53.3 bc	55.6 bc	56.7 bc	64.4 b
	600	63.3 b	100 a	100 a	68.9 b
	800	100 a	100 a	100 a	100 a
C	100	10.0 e	12.2 e	11.1 e	8.9 e
	200	15.5 e	17.8 e	16.7 e	18.9 e
	400	24.4 c	22.2 c	23.3 c	25.6 c
	600	41.1 d	43.3 d	46.7 d	54.4 bc
	800	100 a	61.1 b	100 a	100 a
D	100	13.3 e	14.4 e	26.7 c	15.6 e
	200	31.1 cd	21.1 c	44.4 d	25.6 c
	400	47.8 d	30.0 cd	47.8 d	46.7 d
	600	100 a	51.1 bc	100 a	57.8 bc
	800	100 a	100 a	100 a	100 a
A+B+C+D	100	46.7 d	73.8 b	40.0 d	60.0 b
	200	100 a	100 a	100 a	100 a
	400	100 a	100 a	100 a	100 a
	600	100 a	100 a	100 a	100 a
	800	100 a	100 a	100 a	100 a

Mean values within columns followed by the same letter are not significantly different at P<0.05 (n = 4).
* The fungal growth reduction in different treatments was calculated as percentage relatively to its growth in control treatment
**Where: A= Miconazole B= Chlorohexidine diglucanate C = Chlorocresol D= Hexamidine di-isothianate

Table 1: Reduction in fungal growth in response to different concentrations of some pharmaceutical compounds in vitro conditions.